Austin Private Wealth, LLC Bristol Myers Squibb CO Transaction History

Austin Private Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $68,467 - $77,628	1,427 Added 30.73%	6,070 $329,000
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $48,189 - $57,502	994 Added 27.24%	4,643 $238,000
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $10,362 - $11,586	-179 Reduced 4.68%	3,649 $211,000
Q2 2023 Jul 21, 2023	SELL	$63.71 - $70.74 $6,371 - $7,073	-100 Reduced 2.55%	3,828 $244,000
Q1 2023 Apr 07, 2023	BUY	$65.71 - $74.53 $258,108 - $292,753	3,928 New	3,928 $272,000
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $234,199 - $257,935	3,225 New	3,225 $248,000
Q1 2021 Apr 20, 2021	SELL	$59.34 - $66.74 $751,897 - $845,662	-12,671 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $731,623 - $829,063	12,671 New	12,671 $786,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Austin Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Austin Private Wealth, LLC with notifications on news.